Companies news

Ipsen Announces Dagmar Tschoep as New General Manager for Australia & New Zealand

Dagmar Tschoep joins Ipsen ANZ on 1 October 2025, bringing over two decades of international pharmaceutical leadership.

Ipsen announces that Dagmar Tschoep has taken on the role of General Manager for Australia and New Zealand as of 1 October 2025.

Highly experienced business professional with over 20 years in the pharmaceutical industry, Dagmar's experience spans a diverse range of therapeutic areas, with deep expertise in Immunology, Oncology, Vaccines, and Rare Diseases. Her areas of focus include strategic planning, general management, and communication, and she is a firm believer in authentic and trust-based leadership that encourages diverse teams. She holds an Executive Master of Business Administration (MBA) degree with a focus on Corporate Communication & Stakeholder Relations from Management Center Innsbruck, Boston College, and the University of Cranfield.

Dagmar shared about her new role:

“I’m super excited to take over the leadership for the ANZ team and advance together our Ipsen portfolio, especially bringing the new launches to Australian patients.” 

FACCI congratulates Dagmar on her appointment and wishes her the best in her new role leading Ipsen Australia and New Zealand!

Source: IPSEN